Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polyoxidonium Spray in Children With Acute Respiratory Viral Infection
NCT03840135Phase 3Completed
- Sponsor
- Petrovax Pharm
- Start
- Nov 2018
- Primary completion
- Feb 2019
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azoximer bromide in acute respiratory viral infection (ARVI), sponsored by Petrovax Pharm. Started Nov 2018; status: completed.
02
Drugs
azoximer bromide
03
Conditions
acute respiratory viral infection (ARVI)
Beyond the preview
Go deeper on NCT03840135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03840135.